Assessing the effect of personalized diabetes risk assessments during ophthalmologic visits on glycemic control: A randomized clinical trial

JAMA Ophthalmology

Volumn 133, Issue 8, 2015, Pages 888-896

  Aiello, Lloyd Paul ^a   Ayala, Allison R ^b   Antoszyk, Andrew N ^c   Arnold Bush, Bambi ^b   Baker, Carl ^d   Bressler, Neil M ^e,f   Elman, Michael J ^g   Glassman, Adam R ^b   Jampol, Lee M ^h   Melia, Michele ^b   Nielsen, Jared ⁱ   Wolpert, Howard A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b JAEB CENTER FOR HEALTH RESEARCH   (United States)

^c Charlotte Eye Ear   (United States)

^d Paducah Retinal Center   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f JAMA Ophthalmology   (United States)

^g Elman Retina Group   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ Wolfe Eye Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HEMOGLOBIN VARIANT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ARTERIAL PRESSURE; ARTICLE; ATTITUDE TO HEALTH; BODY MASS; CONTROLLED STUDY; DIABETES EDUCATION; DIABETIC PATIENT; DISEASE SEVERITY; FOLLOW UP; GLYCEMIC CONTROL; HEALTH EDUCATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCOME; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERSONALIZED DIABETES RISK ASSESSMENT; PERSONALIZED MEDICINE; POINT OF CARE TESTING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINOPATHY; RISK ASSESSMENT; SELF CARE; VISUAL ACUITY; AMBULATORY CARE; ANALYSIS; BLOOD; BLOOD PRESSURE; CLINICAL TRIAL; COMPLICATION; DIABETIC RETINOPATHY; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL INFORMATION SYSTEM; MALE; MIDDLE AGED; OPHTHALMOLOGY; PATIENT EDUCATION;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; OFFICE VISITS; OPHTHALMOLOGY; PATIENT EDUCATION AS TOPIC; POINT-OF-CARE SYSTEMS; PRECISION MEDICINE; RISK ASSESSMENT; SELF CARE; VISUAL ACUITY;

EID: 84939483897     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2015.1312     Document Type: Article

References (22)

1. Davis MD, Fisher MR, Gangnon RE, et al. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Invest Ophthalmol Vis Sci. 1998;39(2):233-252.
2. Stratton IM, Kohner EM, Aldington SJ, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia. 2001;44(2): 156-163.
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14): 977-986.
4. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000;342(6):381-389.
5. Nathan DM, Cleary PA, Backlund JY, et al; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl JMed. 2005;353(25):2643-2653.
6. Lasker RD. The diabetes control and complications trial. Implications for policy and practice. N Engl J Med. 1993;329(14):1035-1036.
7. Shaw KM. Overcoming the hurdles to achieving glycemic control. Metabolism. 2006;55 (5 suppl 1):S6-S9.
8. Dagogo-Jack S, Funnell MM, Davidson J. Barriers to achieving optimal glycemic control in a multi-ethnic society: a US focus. Curr Diabetes Rev. 2006;2(3):285-293.
9. Borus JS, Laffel L. Adherence challenges in the management of type 1 diabetes in adolescents: prevention and intervention. Curr Opin Pediatr. 2010;22(4):405-411.
10. Selvin E, Parrinello CM, Sacks DB, Coresh J. Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010. Ann Intern Med. 2014;160(8):517-525.
11. Nam S, Chesla C, Stotts NA, Kroon L, Janson SL. Barriers to diabetes management: patient and provider factors. Diabetes Res Clin Pract. 2011;93(1): 1-9.
12. American Foundation for the Blind (AFB). American foundation for the blind launches web site to help people with vision loss maintain independence. AFBwebsite. http://www.afb.org/info /programs-and-services/professional-development /experts-guide/press-release-archive-3641/1235. Published April 3, 2007. Accessed December 15, 2014.
13. US adults with diabetes fear blindness or vision loss more than premature death. Red Orbit website. http://www.redorbit.com/news/health/757152/us -adults-with-diabetes-fear-blindness-or-vision-loss -more/#hWCv8bhsh8bLZgkF.99. Published December 6, 2006. Accessed December 15, 2014.
14. Salti H, Cavallerano JD, Salti N, et al. Nonmydriatic retinal image review at time of endocrinology visit results in short-term HbA1c reduction in poorly controlled patients with diabetic retinopathy. Telemed J E Health. 2011;17(6): 415-419.
15. Centers for Disease Control and Prevention. National Diabetes Fact Sheet, 2011. http://www.cdc .gov/diabetes/pubs/pdf/ndfs-2011.pdf. Accessed March 11, 2012.
16. Polonsky WH, Anderson BJ, Lohrer PA, et al. Assessment of diabetes-related distress. Diabetes Care. 1995;18(6):754-760.
17. Welch G, Weinger K, Anderson B, Polonsky WH. Responsiveness of the Problem Areas In Diabetes (PAID) questionnaire. Diabet Med. 2003;20(1): 69-72.
18. Cutrona CE, Russell DW. The provisions of social relationships and adaptation to stress. In: Jones WH, Perlman D, eds. Advances in Personal Relationships. Vol 1. Greenwich, CT: JAI Press; 1987: 37-67.
19. La Greca AM, Swales T, Klemp S, Madigan S, Skyler J. Adolescents with diabetes: gender differences in psychosocial functioning and glycemic control. Child Health Care. 1995;24(1): 61-78. doi:10.1207/s15326888chc2401-6.
20. Weinger K, Butler HA, Welch GW, La Greca AM. Measuring diabetes self-care: a psychometric analysis of the Self-Care Inventory-Revised with adults. Diabetes Care. 2005;28(6):1346-1352.
21. Musen G, Jacobson AM, Ryan CM, et al; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Impact of diabetes and its treatment on cognitive function among adolescents who participated in the Diabetes Control and Complications Trial. Diabetes Care. 2008;31(10):1933-1938.
22. García-Pérez LE, Alvarez M, Dilla T, Gil-Guillén V, Orozco-Beltrán D. Adherence to therapies in patients with type 2 diabetes. Diabetes Ther. 2013; 4(2):175-194.